In what is being hailed as a “groundbreaking achievement” for Uruguay and South America, a weight loss drug has successfully ...

Pediatric dermatologists must play an active role in treating obesity in children, according to a presenter at the Society ...

New research indicates that medications commonly prescribed for weight reduction might offer significant benefits for asthma ...

GLP1 agonist drugs, commonly known by brand names such as Ozempic and Mounjaro, reduce asthma symptoms in obese people ...

Researchers says the drugs could be a treatment for obese people with asthma who are ‘often resistant’ to steroids ...

It turns out that obesity may be much more complicated than we thought, with the condition potentially existing in up to 11 ...

For decades, obesity treatment has leaned on temporary fixes—diets, medications, and weight-loss fads. Today, nearly 12 percent of U.S. adults have used a GLP-1 drug.

Obesity has become a global epidemic, contributing to a host of chronic health conditions such as type 2 diabetes, hypertension, and cardiovascular disease.

Obesity treatment has entered a new era with innovative medications offering transformative results. Yet, a troubling reality persists: many who need these life-changing treatments most face the ...

Obesity treatment response was not linked with depression or anxiety in young adulthood and that’s an important finding, the authors noted, ...